These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34571117)

  • 1. Neutralizing interleukin-6 in tumor-bearing mice does not abrogate behavioral fatigue induced by Lewis lung carcinoma.
    Scott K; Phan TT; West AP; Taniguchi CM; Dantzer R
    Behav Brain Res; 2022 Jan; 417():113607. PubMed ID: 34571117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue.
    Grossberg AJ; Vichaya EG; Gross PS; Ford BG; Scott KA; Estrada D; Vermeer DW; Vermeer P; Dantzer R
    Brain Behav Immun; 2020 Aug; 88():230-241. PubMed ID: 32428555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia.
    Vichaya EG; Ford BG; Quave CB; Rishi MR; Grossberg AJ; Dantzer R
    Psychoneuroendocrinology; 2020 Dec; 122():104874. PubMed ID: 32979744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of moxa-grain-moxibustion on serum Th 1/Th 2 type cytokines in Lewis tumor-bearing mice].
    Huang WJ; Wan Q; Xu TS
    Zhen Ci Yan Jiu; 2014 Dec; 39(6):477-81. PubMed ID: 25632573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
    Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
    Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of cisplatin-induced fatigue does not require endogenous interleukin-10 in male mice.
    Scott K; Boukelmoune N; Taniguchi C; West AP; Heijnen CJ; Dantzer R
    Behav Brain Res; 2023 Apr; 444():114381. PubMed ID: 36870396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 abolishes myeloid cell accumulation induced by Lewis lung carcinoma.
    Shin-Ya M; Mazda O; Tsuchihara C; Hirai H; Imanishi J; Takeuchi M
    J Interferon Cytokine Res; 2003 Nov; 23(11):631-8. PubMed ID: 14651777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.
    Saijo Y; Tanaka M; Miki M; Usui K; Suzuki T; Maemondo M; Hong X; Tazawa R; Kikuchi T; Matsushima K; Nukiwa T
    J Immunol; 2002 Jul; 169(1):469-75. PubMed ID: 12077278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer.
    Yao Y; Li H; Chen J; Xu W; Yang G; Bao Z; Xia D; Lu G; Hu S; Zhou J
    Oncotarget; 2016 May; 7(20):29620-34. PubMed ID: 27102437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma.
    Sorrentino R; Morello S; Giordano MG; Arra C; Maiolino P; Adcock IM; Pinto A
    Int J Cancer; 2011 Jun; 128(12):2815-22. PubMed ID: 20725994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-Pyrimidinol Derivative SNK-41 on Cytokine Profile of Mice with Lewis Lung Carcinoma.
    Kuznetsova OS; Tallerova AV; Nikitin SV; Kovalenko LP
    Bull Exp Biol Med; 2016 Feb; 160(4):483-5. PubMed ID: 26906200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice.
    Boelen A; Platvoet-ter Schiphorst MC; Wiersinga WM
    J Endocrinol; 1997 Apr; 153(1):115-22. PubMed ID: 9135576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
    Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
    Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of brain IL-1beta on fatigue after exercise-induced muscle damage.
    Carmichael MD; Davis JM; Murphy EA; Brown AS; Carson JA; Mayer EP; Ghaffar A
    Am J Physiol Regul Integr Comp Physiol; 2006 Nov; 291(5):R1344-8. PubMed ID: 16778069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
    Zhu LX; Sharma S; Stolina M; Gardner B; Roth MD; Tashkin DP; Dubinett SM
    J Immunol; 2000 Jul; 165(1):373-80. PubMed ID: 10861074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Grain-moxibustion on IL-6 and STAT 3 in Inflammatory Microenvironment of Lewis Lung Cancer Mice].
    Zhang X; Wan Q; Xu TS
    Zhen Ci Yan Jiu; 2017 Jun; 42(3):235-9. PubMed ID: 29071980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model.
    Yoshimoto Y; Suzuki Y; Mimura K; Ando K; Oike T; Sato H; Okonogi N; Maruyama T; Izawa S; Noda SE; Fujii H; Kono K; Nakano T
    PLoS One; 2014; 9(3):e92572. PubMed ID: 24686897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.